The impacts of the rise of Paragraph IV challenges on startup alliance formation and firm value in the pharmaceutical industry
Court decisions in 1998 encouraged generic producers to pursue Paragraph IV patent challenges. A follow-up decision in 2000 marked the first successful challenge involving a blockbuster and brought further attention to this pathway for generic entry. We consider the impacts of these decisions on R&D-based startups, and we focus on the propensity to form alliances as a primary channel of impact. We find substantial negative impacts on alliance formation and firm value, and only the first event's impacts are restricted to small molecules. The results suggest that policy analyses in settings with R&D-based startups should consider impacts on alliance formation.
Year of publication: |
2010
|
---|---|
Authors: | Filson, Darren ; Oweis, Ahmed |
Published in: |
Journal of Health Economics. - Elsevier, ISSN 0167-6296. - Vol. 29.2010, 4, p. 575-584
|
Publisher: |
Elsevier |
Keywords: | Intellectual property rights Generic entry Innovation policy Event study Alliances |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Filson, Darren, (2010)
-
Equity Links and Information Acquisition in Biotechnology Alliances
Filson, Darren, (2001)
-
Testing for Contagion during the Asian Crisis
Thanyalakpark, Kessara, (2001)
- More ...